These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19786112)

  • 1. Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation.
    Beck JC; Wagner JE; DeFor TE; Brunstein CG; Schleiss MR; Young JA; Weisdorf DH; Cooley S; Miller JS; Verneris MR
    Biol Blood Marrow Transplant; 2010 Feb; 16(2):215-22. PubMed ID: 19786112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
    Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cytomegalovirus reactivation and tolerability in seropositive umbilical cord transplant patients after implementation of an intensive prevention strategy.
    Rinehart M; Hochard E; Rockey M; Abhyankar S; Ganguly S; Lin T; McGuirk J; Shune L; Singh A; Aljitawi O
    Hematol Oncol Stem Cell Ther; 2016 Sep; 9(3):105-11. PubMed ID: 27013276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation.
    Davis ZB; Cooley SA; Cichocki F; Felices M; Wangen R; Luo X; DeFor TE; Bryceson YT; Diamond DJ; Brunstein C; Blazar BR; Wagner JE; Weisdorf DJ; Horowitz A; Guethlein LA; Parham P; Verneris MR; Miller JS
    Biol Blood Marrow Transplant; 2015 Sep; 21(9):1653-62. PubMed ID: 26055301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.
    Ghobadi A; Milton DR; Gowda L; Rondon G; Chemaly RF; Hamdi A; Alousi A; Afrough A; Oran B; Ciurea S; Kebriaei P; Popat UR; Qazilbash MH; Shpall EJ; Champlin RE; Bashir Q
    Curr Res Transl Med; 2019 May; 67(2):51-55. PubMed ID: 30683577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus infection in seropositive unrelated cord blood recipients: a study of 349 Korean patients.
    Park M; Lee YH; Lee SH; Yoo KH; Sung KW; Koo HH; Lee JW; Kang HJ; Park KD; Shin HY; Ahn HS; Lee JW; Chung NG; Cho B; Kim HK; Koh KN; Im HJ; Seo JJ; Baek HJ; Kook H; Hwang TJ; Lee JM; Hah JO; Lim YJ; Park JE; Lyu CJ; Lim YT; Chong SY; Oh D;
    Ann Hematol; 2015 Mar; 94(3):481-9. PubMed ID: 25417830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and associations with clinical outcomes of cytomegalovirus reactivation after haploidentical versus matched-sibling unmanipulated PBSCT in patients with hematologic malignancies.
    Gao XN; Lin J; Wang LJ; Li F; Li HH; Wang SH; Huang WR; Gao CJ; Yu L; Liu DH
    Ann Hematol; 2020 Aug; 99(8):1883-1893. PubMed ID: 32572523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of risk factors and prognosis of cytomegalovirus infection post umbilical cord blood stem cell transplantation in children with primary immunodeficiency diseases].
    Wei ZL; Qian XW; Wang P; Jiang WJ; Wang HS; Shen C; Wang WJ; Hou J; Wang YH; Huang Y; Wang XC; Zhai XW
    Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1019-1025. PubMed ID: 36207848
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of early CMV reactivation in cord blood stem cell recipients in the current era.
    Ramanathan M; Teira P; Battiwalla M; Barrett J; Ahn KW; Chen M; Green J; Laughlin M; Lazarus HM; Marks D; Saad A; Seftel M; Saber W; Savani B; Waller EK; Wingard J; Auletta JJ; Lindemans CA; Boeckh M; Riches ML
    Bone Marrow Transplant; 2016 Aug; 51(8):1113-20. PubMed ID: 27042847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus reactivation in lymphoma and myeloma patients undergoing autologous peripheral blood stem cell transplantation.
    Massoud R; Assi R; Fares E; Haffar B; Charafeddine M; Kreidieh N; Mahfouz R; Kanj SS; El Zakhem A; Kharfan-Dabaja M; Bazarbachi A; El Cheikh J
    J Clin Virol; 2017 Oct; 95():36-41. PubMed ID: 28843110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients: incidence, risk factors, and outcomes.
    Al-Hajjar S; Al Seraihi A; Al Muhsen S; Ayas M; Al Jumaah S; Al Jefri A; Shoukri M; El Solh H
    Hematol Oncol Stem Cell Ther; 2011; 4(2):67-72. PubMed ID: 21727767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High incidence of cytomegalovirus reactivation in adult recipients of an unrelated cord blood transplant.
    Takami A; Mochizuki K; Asakura H; Yamazaki H; Okumura H; Nakao S
    Haematologica; 2005 Sep; 90(9):1290-2. PubMed ID: 16154862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT.
    Schmidt-Hieber M; Tridello G; Ljungman P; Mikulska M; Knelange N; Blaise D; Socié G; Volin L; Blijlevens N; Fegueux N; Yakoub-Agha I; Forcade E; Maertens J; Chevallier P; Passweg J; Cornelissen J; Russell N; Craddock C; Bourhis JH; Marchand T; Reményi P; Cahn JY; Michallet M; Montoto S; Kröger N; Glaß B; Styczynski J
    Ann Hematol; 2019 Jul; 98(7):1755-1763. PubMed ID: 30993417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon gamma 13-CA-repeat homozygous genotype and a low proportion of CD4(+) lymphocytes are independent risk factors for cytomegalovirus reactivation with a high number of copies in hematopoietic stem cell transplantation recipients.
    Jaskula E; Dlubek D; Duda D; Bogunia-Kubik K; Mlynarczewska A; Lange A
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1296-305. PubMed ID: 19747638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cytomegalovirus (CMV) seroconversion pre-allogeneic hematopoietic cell transplantation on posttransplant outcomes.
    Sayyed A; Wilson L; Stavi V; Chen S; Chen C; Mattsson J; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law AD; Gerbitz A; Pasic I; Novitzky-Basso I; Mazzulli T; Michelis FV
    Eur J Haematol; 2024 Oct; 113(4):441-453. PubMed ID: 38880946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood Transplantation.
    Cao K; Marin D; Sekine T; Rondon G; Zhao W; Smith NT; Daher M; Wang Q; Li L; Saliba RM; Pingali R; Popat U; Hosing C; Olson A; Oran B; Basar R; Mehta RS; Champlin R; Shpall EJ; Rezvani K
    Front Immunol; 2018; 9():2444. PubMed ID: 30405633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis.
    Teira P; Battiwalla M; Ramanathan M; Barrett AJ; Ahn KW; Chen M; Green JS; Saad A; Antin JH; Savani BN; Lazarus HM; Seftel M; Saber W; Marks D; Aljurf M; Norkin M; Wingard JR; Lindemans CA; Boeckh M; Riches ML; Auletta JJ
    Blood; 2016 May; 127(20):2427-38. PubMed ID: 26884374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.
    Lin TS; Zahrieh D; Weller E; Alyea EP; Antin JH; Soiffer RJ
    Transplantation; 2002 Jul; 74(1):49-54. PubMed ID: 12134098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age matters: older age as a risk factor for CMV reactivation in the CMV serostatus-positive kidney transplant recipient.
    Hemmersbach-Miller M; Alexander BD; Pieper CF; Schmader KE
    Eur J Clin Microbiol Infect Dis; 2020 Mar; 39(3):455-463. PubMed ID: 31758441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.